With the systematic review and evaluation of the currently available evidence, we conclude that the therapeutic use of growth factors including EGF, FGF and GM-CSF is effective and safe in the treatment of acute skin wounds, especially in the case of wounds entailing higher risks of infection. This evidence concerns the gene CSF2 and infection.